TP53 and nonpapillary renal cell carcinoma: Moreover, we observed that BAP1, CSMD3, TP53, SETD2, PTEN, PCLO, PIK3CA, and VHL were mutated at a higher frequency in ccRCC-TT patients (Fig. 3b).